In this issue:
British Association of Dermatologists guidelines for the management of HS
Recommendations for HS treatment optimisation from the HS ALLIANCE working group
The anti-inflammatory potency of biologics in HS
Pathogenetic characteristics of mesenchymal stem cells in HS
Psoriasis and HS
Prevalence of acne vulgaris among patients with HS
Adolescent-onset HS
Association between HS and hospitalization for psychiatric disorders
The effect of illness perception on depression, anxiety and quality of life in HS
Clindamycin versus clindamycin plus rifampicin in HS treatment
Cost-savings of adalimumab in HS
Please login below to download this issue (PDF)